Neogen Chemicals Limited — Investor Meet, 18-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Neogen Chemicals has announced a board meeting to consider the financial results for the quarter and half-year. FY25 standalone revenue grew 13% to Rs. 774 Cr with EBITDA rising 24% to a 19% margin. Consolidated revenue was Rs. 778 Cr with a 17.5% EBITDA margin. PAT was affected by a Rs. 13.6 Cr exceptional loss from a fire-related shutdown at Dahej. Hyderabad BuLiChem capacity more than doubled. The battery materials segment posted Rs. 12 Cr revenue and is expanding with a Rs. 1500 Cr CAPEX at Dahej, targeting March 2026 commissioning. Management remains confident in specialty chemicals and lithium-ion battery growth.